KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Gross Profit (2017 - 2025)

Elanco Animal Health's Gross Profit history spans 9 years, with the latest figure at $589.0 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 13.49% year-over-year to $589.0 million; the TTM value through Dec 2025 reached $2.6 billion, up 6.44%, while the annual FY2025 figure was $2.6 billion, 6.44% up from the prior year.
  • Gross Profit for Q4 2025 was $589.0 million at Elanco Animal Health, down from $607.0 million in the prior quarter.
  • Across five years, Gross Profit topped out at $763.0 million in Q1 2023 and bottomed at $519.0 million in Q4 2023.
  • The 5-year median for Gross Profit is $626.0 million (2021), against an average of $632.3 million.
  • The largest annual shift saw Gross Profit soared 150.69% in 2021 before it dropped 11.92% in 2022.
  • A 5-year view of Gross Profit shows it stood at $602.0 million in 2021, then dropped by 10.8% to $537.0 million in 2022, then decreased by 3.35% to $519.0 million in 2023, then changed by 0.0% to $519.0 million in 2024, then rose by 13.49% to $589.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Gross Profit are $589.0 million (Q4 2025), $607.0 million (Q3 2025), and $713.0 million (Q2 2025).